{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:39:08Z","timestamp":1770835148026,"version":"3.50.1"},"reference-count":102,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:00:00Z","timestamp":1199923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p>Hypereosinophilic syndrome (HES) is a rare disorder characterized by persistent and marked eosinophilia. Some HES forms have a poor prognosis, either because of end\u2010organ damage (particularly endomyocardial fibrosis), or because of associated myeloid leukemia or malignant T\u2010cell lymphoma. Oral mucosa ulcerations can be early clinical signs in severe forms. They are discrete, round or oval, sometimes confluent ulcers or erosions, located on non\u2010keratinized, unattached oral mucosa. In the last 15\u2003years a better understanding of eosinophil biology has led to a new clinical classification of HES. The lymphocytic form is characterized by T\u2010lymphocyte clonality, IL\u20105 production, and a possible progression to T\u2010cell lymphoma. Oral lesions are more frequently associated with the myeloproliferative form, characterized by an increased risk of developing myeloid malignancies and a good response to a recent anti\u2010tyrosine kinase therapy (imatinib mesylate). The target of imatinib is a novel kinase resulting from an 800\u2010kb deletion on chromosome 4. Recently, the resulting FIP1L1\u2010PDGFR<jats:italic>\u03b1<\/jats:italic> fusion gene was characterized as a marker of response to imatinib. Exclusion of other erosive ulcerative oral disease and early recognition of HES in patients with oral ulcerations, and precise characterization of the lymphocytic or myeloproliferative form are therefore important to rapidly initiate an effective therapy.<\/jats:p>","DOI":"10.1111\/j.1601-0825.2007.01393.x","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T10:21:38Z","timestamp":1203675698000},"page":"115-122","source":"Crossref","is-referenced-by-count":11,"title":["Oral mucosa lesions in hypereosinophilic syndrome \u2013 an update"],"prefix":"10.1111","volume":"14","author":[{"given":"MA","family":"Ionescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Janin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,10]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.02.019"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2005.tb00764.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/archderm.1996.03890290069009","article-title":"Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition","volume":"132","author":"Aractingi S","year":"1996","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200001000-00005"},{"key":"e_1_2_6_6_1","first-page":"1487","article-title":"Syndromes hyper\u00e9osinophiliques primitifs: actualit\u00e9s","volume":"133","author":"Ballanger F","year":"2006","journal-title":"Ann Dermatol"},{"key":"e_1_2_6_7_1","first-page":"207","article-title":"Mucosal ulcerations revealing primitive hypereosinophilic syndrome","volume":"13","author":"Barouky R","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_8_1","first-page":"248","article-title":"Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome","volume":"124","author":"Billon C","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116008"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000085560"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197501000-00001"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.V75.9.1774.bloodjournal7591774","article-title":"Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin\u20101 (rhIL\u20101), rhIL\u20103, rhIL\u20105, rhIL\u20106, and rh granulocyte\u2010macrophage colony\u2010stimulating factor","volume":"75","author":"Clutterbuck EJ","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402243300804"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.4.1169"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.5.583"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025217"},{"key":"e_1_2_6_17_1","first-page":"243","article-title":"Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases","volume":"144","author":"Coutant G","year":"1993","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290006323"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.8.3033"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114368"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.1.293"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood.V82.5.1553.1553","article-title":"Synthesis of interleukin\u20105 by activated eosinophils in patients with eosinophilic heart diseases","volume":"82","author":"Desreumaux P","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.132"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608886"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4494"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441401"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000475293","article-title":"Evidence for eosinophil activation in eosinophilic cystitis","volume":"25","author":"Dubucquoi S","year":"1994","journal-title":"Eur Urol"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.2.242"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-1-78"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03404.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.049"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.4.2285"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.09.008"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08505-7"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000236892"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1159\/000085559"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1824"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001115)89:10<2138::AID-CNCR15>3.0.CO;2-W"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0932698100"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-68-6-1220"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.02.059"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-005-0288-0"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.03.003"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21186"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.03.001"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01611183"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.48.1.57"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-12-199406150-00004"},{"key":"e_1_2_6_49_1","first-page":"662","article-title":"Familial peeling skin syndrome with eosinophilia: clinical, histologic, and ultrastructural study of three cases","volume":"120","author":"Janin A","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_50_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4049\/jimmunol.126.2.468","article-title":"Peroxidase\u2010mediated toxicity to schistosomula of Schistosoma mansoni","volume":"126","author":"Jong EC","year":"1981","journal-title":"J Immunol"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1978.01640160009003"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(02)00609-X"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04456.x"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709059688"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0006"},{"key":"e_1_2_6_56_1","first-page":"394","article-title":"An unusual cause of vascular purpura: recurrent cutaneous eosinophilic necrotizing vasculitis","volume":"80","author":"Launay D","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70166-Y"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.051"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.247.7.1018"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.863"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1496::AID-IMMU1496>3.0.CO;2-5"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(97)00268-5"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.11.6273"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6560"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90330-1"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.99.4.630"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3103"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.3.421"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0702356"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05206.x"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031261"},{"key":"e_1_2_6_72_1","first-page":"753","article-title":"6q\u2010 is an early and persistent chromosomal aberration in CD3\u2010CD4+ T\u2010cell clones associated with the lymphocytic variant of hypereosinophilic syndrome","volume":"90","author":"Ravoet M","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805283382206"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.790118.x"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.4.785"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02097.x"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.54.101601.152431"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118417"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.13.4285"},{"key":"e_1_2_6_81_1","first-page":"2689","volume-title":"Rook\/Wilkinson\/Ebling's Textbook of Dermatology","author":"Scully C","year":"1992"},{"key":"e_1_2_6_82_1","first-page":"2689","volume-title":"Rook\/Wilkinson\/Ebling's Textbook of Dermatology","author":"Scully C","year":"1992"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04801.x"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910073411503"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1159\/000091326"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.02.006"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.05048"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.06025"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70085-X"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.00268.x"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.109826"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400717"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03771.x"},{"key":"e_1_2_6_94_1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1365-2222.1999.00511.x","article-title":"Interleukin\u20105 immunoreactivity and mRNA expression in gut mucosa from patients with food allergy","volume":"29","author":"Vandezande LM","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.146.7.1440"},{"key":"e_1_2_6_96_1","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.147.10.3490","article-title":"Glucocorticoids inhibit cytokine\u2010mediated eosinophil survival","volume":"147","author":"Wallen N","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70069-2"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(94)90038-8"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.10.2759.2759"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20423"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2000.tb02131.x"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01729838"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.139"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.2007.01393.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.2007.01393.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:03:17Z","timestamp":1696975397000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.2007.01393.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,10]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1601-0825.2007.01393.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.2007.01393.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,10]]}}}